UROLOGICAL SURVEY   ( Download pdf )

 

STONE DISEASE

Appropriate Cutoff for Treatment of Distal Ureteral Stones by Single Session In Situ Extracorporeal Shock Wave Lithotripsy
Akhtar S, Ather MH
Department of Surgery, Aga Khan University, Karachi, Pakistan
Urology. 2005; 66: 1165-8

  • Objectives: To determine an appropriate cutoff for treatment by single session in situ extracorporeal shock wave lithotripsy for a prevesical stone by determining the differences in the efficiency quotient (EQ).
  • Methods: This was a review of a series of patients who underwent shock wave lithotripsy for a primary, single, prevesical stone from January 1995 to June 2003. All 153 patients were treated using a Dornier MPL 9000 lithotripter in the prone position under intravenous sedation. The stone size was measured in two dimensions (parallel and perpendicular to the long axis of the ureter). The EQ was calculated using a standard formula.
  • Results: Of the 153 patients, 141 (92.2%) were stone free within a mean period of 12.2 +/- 12.2 days (EQ 68.8). No significant complications occurred, and none of the patients required admission. The treatment failed in 10 patients (6.5%), who subsequently required an ancillary procedure (ureteroscopy). Statistically, we found 7 mm to be an appropriate cutoff for treatment using in situ shock wave lithotripsy. The EQ for stones greater than 7 mm and those 7 mm or smaller was 58 and 81, with a stone-free period of 13.6 +/- 12.9 and 10.9 +/- 11.6 days, respectively.
  • Conclusions: Ultrasound-guided shock wave lithotripsy is an efficient and safe modality for the treatment of prevesical stones 7 mm or less. Using an echo-guided lithotripter, the treatment was a radiation-free, day care procedure performed under intravenous sedation. Only 11% of our patients required repeat treatment.

  • Editorial Comment
    The optimal treatment of distal ureteral stones remains one of the more controversial topics in endourology. Both procedures are associated with high success rates and low complication rates. In situ SWL with the Dornier HM3 has been shown in a number of series to be associated with remarkably high stone free rates and low retreatment rates, even for stones up to 15 mm in size (1,2). Although high stone free rates have also been achieved with third generation lithotripters, retreatment rates, particularly for larger stones, have been higher than in HM3 series. Akhtar & Ather compared stone free and retreatment rates for in situ SWL of distal ureteral stones £ 7 mm or > 7 mm in size in a retrospective analysis of 153 patients treated with a MPL9000 lithotripter. Although stone free rates were quite high in both size categories (95% versus 89%, respectively), retreatment rates were significantly higher in the larger stone group (45% versus 11%, respectively), translating into an efficiency quotient of 81 for treatment of stones £ 7 mm and 58 for stones > 7mm. Although this size cutoff was chosen randomly, it provides a reasonable algorithm to guide treatment of distal ureteral calculi when considering treatment with a third generation lithotripter. For stones £ 7 mm in size, ureteroscopy or in situ SWL are certainly reasonable treatment options. However, for stones > 7 mm in size, the high success rate and low retreatment rate of ureteroscopy makes this treatment option more attractive then SWL if an HM3 is not available.

References
1. Hochreiter WW, Danuser H, Perrig M, Studer UE: Extracorporeal shock wave lithotripsy for distal ureteral calculi: what a powerful machine can achieve. J Urol. 2003; 169: 878-80.
2. Pearle MS, Nadler R, Bercowsky E, Chen C, Dunn M, Figenshau RS, Hoenig DM, McDougall EM, Mutz J, Nakada SY, Shalhav AL, Sundaram C, Wolf JS Jr., Clayman RV: Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for management of distal ureteral calculi. J Urol. 2001; 166: 1255-60.

Dr. Margaret S. Pearle
Associate Professor of Urology
University of Texas Southwestern Med Ctr
Dallas, Texas, USA